HAP Trading’s Anavex Life Sciences AVXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-12,500
Closed -$1.88K 1040
2023
Q2
$1.88K Sell
12,500
-3,900
-24% -$33.4K ﹤0.01% 1005
2023
Q1
$8K Sell
16,400
-22,700
-58% -$227K ﹤0.01% 914
2022
Q4
$33K Sell
39,100
-1,800
-4% -$19.2K ﹤0.01% 840
2022
Q3
$71K Sell
40,900
-10,400
-20% -$110K ﹤0.01% 886
2022
Q2
$70K Sell
51,300
-12,400
-19% -$117K ﹤0.01% 976
2022
Q1
$82K Buy
63,700
+42,900
+206% +$528K ﹤0.01% 1117
2021
Q4
$31K Buy
20,800
+700
+3% +$13.3K ﹤0.01% 1661
2021
Q3
$30K Sell
20,100
-17,800
-47% -$354K ﹤0.01% 1672
2021
Q2
$225K Buy
37,900
+400
+1% +$5.92K 0.01% 961
2021
Q1
$176K Buy
37,500
+16,100
+75% +$176K 0.01% 798
2020
Q4
$12K Buy
21,400
+7,400
+53% +$39K ﹤0.01% 1854
2020
Q3
$15K Buy
+14,000
New +$60.3K ﹤0.01% 1229
2017
Q2
Sell
-14,100
Closed -$5K 940
2017
Q1
$5K Buy
+14,100
New +$72.8K ﹤0.01% 952

Other funds holding AVXL